Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions-Reference-Cited by-同舟云学术

Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions

Published:2018-10-25 Issue:46 Volume:39 Page:4101-4108
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Kalkman Deborah N¹²,Aquino Melissa¹,Claessen Bimmer E¹,Baber Usman¹,Guedeney Paul¹,Sorrentino Sabato¹,Vogel Birgit¹,de Winter Robbert J²,Sweeny Joseph¹,Kovacic Jason C¹,Shah Srushti¹,Vijay Pooja¹,Barman Nitin¹,Kini Annapoorna¹,Sharma Samin¹,Dangas George D¹,Mehran Roxana¹

Affiliation:

1. Center for Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai Hospital, New York, One Gustave L. Levy Place, Box 1030, New York, NY, USA

2. Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences, Meibergdreef 9, AZ, Amsterdam, The Netherlands

Funder

Amsterdam Cardiovascular Sciences

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/39/46/4101/27078958/ehy633.pdf

Reference27 articles.

1. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty;de Winter;Eur Heart J,2002

2. C-reactive protein elevation and disease activity in patients with coronary artery disease;Arroyo-Espliguero;Eur Heart J,2004

3. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

4. Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin;Ridker;Eur Heart J,2016

5. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR);Piepoli;Eur Heart J,2016

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease;European Heart Journal;2024-08-30

2. C-Reactive Protein: An Important Inflammatory Marker of Coronary Atherosclerotic Disease;Angiology;2024-08-10

3. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

4. Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition – a case based review;Expert Review of Cardiovascular Therapy;2024-08-02

5. The combined effect of triglyceride–glucose index and high‐sensitivity C‐reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study;Journal of Diabetes;2024-08